Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer
- Authors:
- Birdal Bilir
- Nitya V. Sharma
- Jeongseok Lee
- Bato Hammarstrom
- Aud Svindland
- Omer Kucuk
- Carlos S. Moreno
-
Affiliations: Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA, Department of Urology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway, Department of Clinical Medicine, University of Oslo, Oslo, Norway, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA - Published online on: May 24, 2017 https://doi.org/10.3892/ijo.2017.4017
- Pages: 223-234
This article is mentioned in:
Abstract
 |
 |
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Prostate Cancer Facts and Figures 2016. American Cancer Society Inc; Atlanta, GA: 2016 | |
|
Dunn MW and Kazer MW: Prostate cancer overview. Semin Oncol Nurs. 27:241–250. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sartor AO: Progression of metastatic castrate-resistant prostate cancer: Impact of therapeutic intervention in the post-docetaxel space. J Hematol Oncol. 4:182011. View Article : Google Scholar : PubMed/NCBI | |
|
Skolarus TA, Wolf AMD, Erb NL, Brooks DD, Rivers BM, Underwood W III, Salner AL, Zelefsky MJ, Aragon-Ching JB, Slovin SF, et al: American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 64:225–249. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hieronymus H, Schultz N, Gopalan A, Carver BS, Chang MT, Xiao Y, Heguy A, Huberman K, Bernstein M, Assel M, et al: Copy number alteration burden predicts prostate cancer relapse. Proc Natl Acad Sci USA. 111:11139–11144. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ferlay J, Bray F, Pisani P and Parkin DM: Globocan 2000: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Press; Lyon: 2001 | |
|
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kimura T: East meets West: Ethnic differences in prostate cancer epidemiology between East Asians and Caucasians. Chin J Cancer. 31:421–429. 2012. View Article : Google Scholar | |
|
Reinli K and Block G: Phytoestrogen content of foods–a compendium of literature values. Nutr Cancer. 26:123–148. 1996. View Article : Google Scholar | |
|
Adlercreutz H, Markkanen H and Watanabe S: Plasma concentrations of phyto-oestrogens in Japanese men. Lancet. 342:1209–1210. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Morton MS, Chan PS, Cheng C, Blacklock N, Matos-Ferreira A, Abranches-Monteiro L, Correia R, Lloyd S and Griffiths K: Lignans and isoflavonoids in plasma and prostatic fluid in men: Samples from Portugal, Hong Kong, and the United Kingdom. Prostate. 32:122–128. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Hwang YW, Kim SY, Jee SH, Kim YN and Nam CM: Soy food consumption and risk of prostate cancer: A meta-analysis of observational studies. Nutr Cancer. 61:598–606. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Van Poppel H and Tombal B: Chemoprevention of prostate cancer with nutrients and supplements. Cancer Manag Res. 3:91–100. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Barnes S, Peterson TG and Coward L: Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem (Suppl). S22:181–187. 1995. View Article : Google Scholar | |
|
Takimoto CH, Glover K, Huang X, Hayes SA, Gallot L, Quinn M, Jovanovic BD, Shapiro A, Hernandez L, Goetz A, et al: Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiol Biomarkers Prev. 12:1213–1221. 2003.PubMed/NCBI | |
|
Gardner CD, Oelrich B, Liu JP, Feldman D, Franke AA and Brooks JD: Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation. Prostate. 69:719–726. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, Dix KJ, Thomas BF, Albright C, Busby MG, Crowell JA, et al: Safety and pharmacokinetics of purified soy isoflavones: Single-dose administration to postmenopausal women. Am J Clin Nutr. 76:1126–1137. 2002.PubMed/NCBI | |
|
Yildiz F: Phytoestrogens in functional foods. CRC Press; Boca Raton, FL: 2005, https://doi.org/10.1201/9781420027594. View Article : Google Scholar | |
|
Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M and Masamune Y: Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull. 24:351–356. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Chang WY and Prins GS: Estrogen receptor-beta: Implications for the prostate gland. Prostate. 40:115–124. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar R, Verma V, Jain A, Jain RK, Maikhuri JP and Gupta G: Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer. J Nutr Biochem. 22:723–731. 2011. View Article : Google Scholar | |
|
Wang J, Eltoum IE and Lamartiniere CA: Genistein chemoprevention of prostate cancer in TRAMP mice. J Carcinog. 6:32007. View Article : Google Scholar : PubMed/NCBI | |
|
Davis JN, Kucuk O and Sarkar FH: Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells. Mol Carcinog. 34:91–101. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Bektic J, Berger AP, Pfeil K, Dobler G, Bartsch G and Klocker H: Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta. Eur Urol. 45:245–251; discussion 251. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Shen JC, Klein RD, Wei Q, Guan Y, Contois JH, Wang TT, Chang S and Hursting SD: Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells. Mol Carcinog. 29:92–102. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Davis JN, Singh B, Bhuiyan M and Sarkar FH: Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer. 32:123–131. 1998. View Article : Google Scholar | |
|
Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH and Hillman GG: Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer. 6:1072006. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y and Sarkar FH: Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett. 186:157–164. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Guo Y, Wang S, Hoot DR and Clinton SK: Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. J Nutr Biochem. 18:408–417. 2007. View Article : Google Scholar | |
|
Li Y, Che M, Bhagat S, Ellis KL, Kucuk O, Doerge DR, Abrams J, Cher ML and Sarkar FH: Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia. 6:354–363. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang LL, Li L, Wu DP, Fan JH, Li X, Wu KJ, Wang XY and He DL: A novel anti-cancer effect of genistein: Reversal of epithelial mesenchymal transition in prostate cancer cells. Acta Pharmacol Sin. 29:1060–1068. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kumi-Diaka JK, Hassanhi M, Merchant K and Horman V: Influence of genistein isoflavone on matrix metalloproteinase-2 expression in prostate cancer cells. J Med Food. 9:491–497. 2006. View Article : Google Scholar | |
|
Kazi A, Daniel KG, Smith DM, Kumar NB and Dou QP: Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem Pharmacol. 66:965–976. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kumi-Diaka J, Sanderson NA and Hall A: The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP. Biol Cell. 92:595–604. 2000. View Article : Google Scholar | |
|
Lee J, Ju J, Park S, Hong SJ and Yoon S: Inhibition of IGF-1 signaling by genistein: Modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells. Nutr Cancer. 64:153–162. 2012. View Article : Google Scholar | |
|
Xu L and Bergan RC: Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway. Mol Pharmacol. 70:869–877. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Davis JN, Kucuk O and Sarkar FH: Genistein inhibits NF-kappaB activation in prostate cancer cells. Nutr Cancer. 35:167–174. 1999. View Article : Google Scholar | |
|
Li Y and Sarkar FH: Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res. 8:2369–2377. 2002.PubMed/NCBI | |
|
Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M and Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 262:5592–5595. 1987.PubMed/NCBI | |
|
Park CE, Yun H, Lee EB, Min BI, Bae H, Choe W, Kang I, Kim SS and Ha J: The antioxidant effects of genistein are associated with AMP-activated protein kinase activation and PTEN induction in prostate cancer cells. J Med Food. 13:815–820. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Raschke M, Rowland IR, Magee PJ and Pool-Zobel BL: Genistein protects prostate cells against hydrogen peroxide-induced DNA damage and induces expression of genes involved in the defence against oxidative stress. Carcinogenesis. 27:2322–2330. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Swami S, Krishnan AV, Moreno J, Bhattacharyya RS, Gardner C, Brooks JD, Peehl DM and Feldman D: Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. Int J Cancer. 124:2050–2059. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Adjakly M, Bosviel R, Rabiau N, Boiteux JP, Bignon YJ, Guy L and Bernard-Gallon D: DNA methylation and soy phytoestrogens: Quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics. 3:795–803. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, Dechelotte P, Boiteux JP, Fontana L, Bignon YJ, Guy L, et al: Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo. 24:393–400. 2010.PubMed/NCBI | |
|
Fang MZ, Chen D, Sun Y, Jin Z, Christman JK and Yang C: Reversal of hypermethylation and reactivation of 16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res. 11:7033–7041. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, Tanaka Y, Dahiya AV and Dahiya R: Genistein reverses hyper-methylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer. 116:66–76. 2010. | |
|
Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Majid S, Igawa M and Dahiya R: Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer. 123:552–560. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Kong D, Ahmad A, Bao B, Dyson G and Sarkar FH: Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Epigenetics. 7:940–949. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rabiau N, Trraf HK, Adjakly M, Bosviel R, Guy L, Fontana L, Bignon YJ and Bernard-Gallon DJ: miRNAs differentially expressed in prostate cancer cell lines after soy treatment. In Vivo. 25:917–921. 2011.PubMed/NCBI | |
|
Chen Y, Zaman MS, Deng G, Majid S, Saini S, Liu J, Tanaka Y and Dahiya R: MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila). 4:76–86. 2011. View Article : Google Scholar | |
|
Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, et al: Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One. 8:e589292013. View Article : Google Scholar : PubMed/NCBI | |
|
Hillman GG, Forman JD, Kucuk O, Yudelev M, Maughan RL, Rubio J, Layer A, Tekyi-Mensah S, Abrams J and Sarkar FH: Genistein potentiates the radiation effect on prostate carcinoma cells. Clin Cancer Res. 7:382–390. 2001.PubMed/NCBI | |
|
Li Y, Kucuk O, Hussain M, Abrams J, Cher ML and Sarkar FH: Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Res. 66:4816–4825. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Spagnuolo C, Russo GL, Orhan IE, Habtemariam S, Daglia M, Sureda A, Nabavi SF, Devi KP, Loizzo MR, Tundis R, et al: Genistein and cancer: Current status, challenges, and future directions. Adv Nutr. 6:408–419. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Katoh M: Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells. Curr Pharm Biotechnol. 12:160–170. 2011. View Article : Google Scholar | |
|
Mori R, Wang Q, Danenberg KD, Pinski JK and Danenberg PV: Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate. 68:1555–1560. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Reich M, Liefeld T, Gould J, Lerner J, Tamayo P and Mesirov JP: GenePattern 2.0. Nat Genet. 38:500–501. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Eisen MB, Spellman PT, Brown PO and Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Saldanha AJ: Java Treeview - extensible visualization of micro-array data. Bioinformatics. 20:3246–3248. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Barfield RT, Kilaru V, Smith AK and Conneely KN: CpGassoc: An R function for analysis of DNA methylation microarray data. Bioinformatics. 28:1280–1281. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
http://www.qiagen.com/ingenuity. Qiagen's Ingenuity Pathway Analysis. | |
|
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC and Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4:32003. View Article : Google Scholar | |
|
Wang Z and Chen H: Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. Anticancer Res. 30:4537–4545. 2010.PubMed/NCBI | |
|
Gao BN and Gilman AG: Cloning and expression of a widely distributed (type IV) adenylyl cyclase. Proc Natl Acad Sci USA. 88:10178–10182. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Brikun I, Nusskern D, Gillen D, Lynn A, Murtagh D, Feczko J, Nelson WG and Freije D: A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients. Biomark Res. 2:252014. View Article : Google Scholar : PubMed/NCBI | |
|
Monti E, Bonten E, D'Azzo A, Bresciani R, Venerando B, Borsani G, Schauer R and Tettamanti G: Sialidases in vertebrates: A family of enzymes tailored for several cell functions. Adv Carbohydr Chem Biochem. 64:403–479. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Uemura T, Shiozaki K, Yamaguchi K, Miyazaki S, Satomi S, Kato K, Sakuraba H and Miyagi T: Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4. Oncogene. 28:1218–1229. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kato T, Wang Y, Yamaguchi K, Milner CM, Shineha R, Satomi S and Miyagi T: Overexpressing of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells. Int J Cancer. 92:797–804. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Chang S, He S, Qiu G, Lu J, Wang J, Liu J, Fan L, Zhao W and Che X: MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1. Tumour Biol. 37:12141–12151. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Haxho F, Neufeld RJ and Szewczuk MR: Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis. Oncotarget. 7:40860–40881. 2016.PubMed/NCBI | |
|
Liu L, Chen X, Wang Y, Qu Z, Lu Q, Zhao J, Yan X, Zhang H and Zhou Y: Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1. Cancer Gene Ther. 21:364–372. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Danza G, Di Serio C, Ambrosio MR, Sturli N, Lonetto G, Rosati F, Rocca BJ, Ventimiglia G, del Vecchio MT, Prudovsky I, et al: Notch3 is activated by chronic hypoxia and contributes to the progression of human prostate cancer. Int J Cancer. 133:2577–2586. 2013.PubMed/NCBI | |
|
Terada N, Shiraishi T, Zeng Y, Aw-Yong KM, Mooney SM, Liu Z, Takahashi S, Luo J, Lupold SE, Kulkarni P, et al: Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation. J Cell Biochem. 115:1505–1515. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pedrosa AR, Graça JL, Carvalho S, Peleteiro MC, Duarte A and Trindade A: Notch signaling dynamics in the adult healthy prostate and in prostatic tumor development. Prostate. 76:80–96. 2016. View Article : Google Scholar | |
|
Pedrosa AR, Trindade A, Carvalho C, Graça J, Carvalho S, Peleteiro MC, Adams RH and Duarte A: Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions. Oncotarget. 6:24404–24423. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Danza G, Di Serio C, Rosati F, Lonetto G, Sturli N, Kacer D, Pennella A, Ventimiglia G, Barucci R, Piscazzi A, et al: Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cells. Mol Cancer Res. 10:230–238. 2012. View Article : Google Scholar | |
|
Rampias T, Vgenopoulou P, Avgeris M, Polyzos A, Stravodimos K, Valavanis C, Scorilas A and Klinakis A: A new tumor suppressor role for the Notch pathway in bladder cancer. Nat Med. 20:1199–1205. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hernandez Tejada FN, Galvez Silva JR and Zweidler-McKay PA: The challenge of targeting notch in hematologic malignancies. Front Pediatr. 2:542014. View Article : Google Scholar : PubMed/NCBI | |
|
Giachino C, Boulay JL, Ivanek R, Alvarado A, Tostado C, Lugert S, Tchorz J, Coban M, Mariani L, Bettler B, et al: A tumor suppressor function for Notch signaling in forebrain tumor subtypes. Cancer Cell. 28:730–742. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Jaskula-Sztul R, Eide J, Tesfazghi S, Dammalapati A, Harrison AD, Yu XM, Scheinebeck C, Winston-McPherson G, Kupcho KR, Robers MB, et al: Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction. Mol Cancer Ther. 14:499–512. 2015. View Article : Google Scholar | |
|
Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB and Ball DW: Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 61:3200–3205. 2001.PubMed/NCBI | |
|
Liu YL, Zhang GQ, Yang Y, Zhang CY, Fu RX and Yang YM: Genistein induces G2/M arrest in gastric cancer cells by increasing the tumor suppressor PTEN expression. Nutr Cancer. 65:1034–1041. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Cheng HL, Hsu PY and Chow NH: The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem Pharmacol. 69:307–318. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jagadeesh S, Kyo S and Banerjee PP: Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res. 66:2107–2115. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Mahmoud AM, Al-Alem U, Ali MM and Bosland MC: Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation. J Steroid Biochem Mol Biol. 152:62–75. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Whirledge S, Senbanjo LT and Cidlowski JA: Genistein disrupts glucocorticoid receptor signaling in human uterine endometrial Ishikawa cells. Environ Health Perspect. 123:80–87. 2015. | |
|
Bhamre S, Sahoo D, Tibshirani R, Dill DL and Brooks JD: Gene expression changes induced by genistein in the prostate cancer cell line LNCaP. Open Prostate Cancer J. 3:86–98. 2010. View Article : Google Scholar | |
|
Ghaemi A, Soleimanjahi H, Razeghi S, Gorji A, Tabaraei A, Moradi A, Alizadeh A and Vakili MA: Genistein induces a protective immunomodulatory effect in a mouse model of cervical cancer. Iran J Immunol. 9:119–127. 2012.PubMed/NCBI | |
|
Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN, Pike MC, Hoover RN and Ziegler RG: Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev. 18:1050–1059. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SA, Shu XO, Li H, Yang G, Cai H, Wen W, Ji BT, Gao J, Gao YT and Zheng W: Adolescent and adult soy food intake and breast cancer risk: Results from the Shanghai Women's Health Study. Am J Clin Nutr. 89:1920–1926. 2009. View Article : Google Scholar : PubMed/NCBI |
